Skull Base 2010; 20(3): 169-177
DOI: 10.1055/s-0030-1247634
ORIGINAL ARTICLE

© Thieme Medical Publishers

Parotid and Temporal Bone Resection for Skull Base Malignancies: Outcome

Zoukaa Sargi1 , Robert Gerring1 , Simon Angeli2 , David Arnold1 , Adrien Eshraghi2 , Francisco Civantos1 , Fred Telischi2 , Donald Weed1
  • 1Division of Head and Neck Surgery, University of Miami Miller School of Medicine, Miami, Florida
  • 2Division of Neurotology, University of Miami Miller School of Medicine, Miami, Florida
Further Information

Publication History

Publication Date:
29 January 2010 (online)

ABSTRACT

We reviewed the outcome of and determined prognostic factors for patients undergoing combined lateral skull base resection for advanced lateral skull base malignancies. We performed a retrospective, single-institution case series in an academic tertiary care hospital. Seventy-nine patients with combined temporal bone resection and parotidectomy for advanced lateral skull base malignancy were included. Main outcome measures were overall survival and disease-free survival. The mean follow-up time was 18.3 months, with an overall survival of 64.5 months and disease-free survival of 42.6 months. Disease-free survival was 36.2 months for skin tumors, 42.7 months for salivary glands tumors, and 8.5 months for tumors of mesenchymal origin. Log-rank tests for prognostic indicators demonstrated that temporal bone erosion on computed tomography (CT) scan (p = 0.009) and histology (p = 0.045) were statistically significant predictors of poor outcome. Subtotal resection of the facial nerve and positive lymph nodes were associated with poor outcome in tumors arising from skin. Advanced malignancies of the lateral skull base are best managed using a combined lateral temporal bone resection and parotidectomy, with a 50% disease-specific survival of 32 months. Malignant mesenchymal tumors as well as presence of temporal bone erosion on preoperative CT scan are associated with poor prognosis.

REFERENCES

  • 1 McGrew B M, Jackson C G, Redtfeldt R A. Lateral skull base malignancies.  Neurosurg Focus. 2002;  12 e8
  • 2 Parsons H, Lewis J S. Subtotal resection of the temporal bone for cancer of the ear.  Cancer. 1954;  7 995-1001
  • 3 Medina J E, Park A O, Neely J G, Britton B H. Lateral temporal bone resections.  Am J Surg. 1990;  160 427-433
  • 4 Allen G W. Anew technique employing partial temporal bone resection in parotid gland surgery for cancer.  Surg Clin North Am. 1966;  46 131-143
  • 5 Manolidis S, Pappas Jr D, Von Doersten P, Jackson C G, Glasscock III M E. Temporal bone and lateral skull base malignancy: experience and results with 81 patients.  Am J Otol. 1998;  19(6 Suppl) S1-S15
  • 6 Moore M G, Deschler D G, McKenna M J, Varvares M A, Lin D T. Management outcomes following lateral temporal bone resection for ear and temporal bone malignancies.  Otolaryngol Head Neck Surg. 2007;  137 893-898
  • 7 Martinez-Devesa P, Barnes M L, Milford C A. Malignant tumors of the ear and temporal bone: a study of 27 patients and review of their management.  Skull Base. 2008;  18 1-8
  • 8 Ito M, Hatano M, Yoshizaki T. Prognostic factors for squamous cell carcinoma of the temporal bone: extensive bone involvement or extensive soft tissue involvement?.  Acta Otolaryngol. 2009;  129 1313-1316

Zoukaa SargiM.D. 

University of Miami Hospital and Clinics

1475 NW 12th Avenue # 4025, Miami, FL 33136

Email: ZSargi@med.miami.edu

    >